Hepatocyte growth factor and Met in drug discovery

Journal of Biochemistry
Katsuya SakaiK Matsumoto

Abstract

Activation of the hepatocyte growth factor (HGF)-Met pathway evokes dynamic biological responses that support the morphogenesis, regeneration and survival of cells and tissues. A characterization of conditional Met knockout mice indicates that the HGF-Met pathway plays important roles in the regeneration, protection and homeostasis of cells such as hepatocytes, renal tubular cells and neurons. Preclinical studies in disease models have indicated that recombinant HGF protein and expression plasmid for HGF are biological drug candidates for the treatment of patients with diseases or injuries that involve impaired tissue function. The phase-I and phase-I/II clinical trials of the intrathecal administration of HGF protein for the treatment of patients with amyotrophic lateral sclerosis and spinal cord injury, respectively, are ongoing. Biological actions of HGF that promote the dynamic movement, morphogenesis and survival of cells also closely participate in invasion-metastasis and resistance to the molecular-targeted drugs in tumour cells. Different types of HGF-Met pathway inhibitors are now in clinical trials for treatment of malignant tumours. Basic research on HGF and Met has lead to drug discoveries in regenerative medicine a...Continue Reading

References

Sep 16, 1991·Biochemical and Biophysical Research Communications·A MorimotoM Kuwano
Feb 1, 1991·Journal of Cellular Physiology·E M RosenI D Goldberg
Nov 1, 1990·The Journal of Cell Biology·K M WeidnerW Birchmeier
Sep 15, 1989·Biochemical and Biophysical Research Communications·K MiyazawaK Takahashi
Oct 1, 1989·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·K MatsumotoS Enomoto
Apr 16, 1998·Biochemical and Biophysical Research Communications·K KosaiT Nakamura
Sep 20, 2000·The Journal of Cell Biology·M SachsW Birchmeier
Jun 13, 2002·The Journal of Dermatological Treatment·F NayeriP Forsberg
Oct 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nikolaus SchieringCinzia Cristiani
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Chang-Goo HuhSnorri S Thorgeirsson
May 29, 2004·The EMBO Journal·Jennifer StamosChristian Wiesmann
Jun 29, 2004·The Journal of Pathology·Damon BevanRichard Warn
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Malgorzata BorowiakCarmen Birchmeier
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Feb 3, 2006·International Journal of Cancer. Journal International Du Cancer·Kunio Matsumoto, Toshikazu Nakamura
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Weiru WangBrian L West
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ermanno GherardiDmitri I Svergun
Oct 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Daniel B CampbellPat Levitt
Apr 4, 2007·The Journal of Cell Biology·Jolanta ChmielowiecWalter Birchmeier
Apr 4, 2008·The American Journal of Pathology·Gaelle del CastilloAránzazu Sánchez
May 23, 2008·The Journal of Biological Chemistry·Cristina BasilicoPaolo Michieli
May 31, 2008·Nature Reviews. Drug Discovery·Paolo M ComoglioLivio Trusolino
Apr 25, 2009·The American Journal of Pathology·Nils BuchsteinSabine A Eming
Jun 18, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Satoshi MoritaToshihiro Nukiwa

❮ Previous
Next ❯

Citations

Feb 18, 2016·Clinical Oncology : a Journal of the Royal College of Radiologists·J LeeS J Klempner
Sep 29, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Pérez-RamírezMiguel Ángel Calleja-Hernández
Sep 13, 2015·Drug Development Research·Zeynep F KaragonlarNeşe Atabey
Dec 17, 2016·Cell Communication and Signaling : CCS·Nishant P VisavadiyaTheo Hagg
Jan 6, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark M AwadLynette M Sholl
Jan 9, 2017·Cancer Science·Kunio MatsumotoDonald P Bottaro
Mar 28, 2018·International Journal of Cancer. Journal International Du Cancer·Peter WirthschaftBjörn Tews
Jan 20, 2017·American Journal of Physiology. Cell Physiology·Sean M Gross, Peter Rotwein
Jul 5, 2017·Biochemical Society Transactions·Dinuka M De SilvaDonald P Bottaro
Jul 29, 2016·World Journal of Gastroenterology : WJG·Sarah HeilerMargot Zöller
Oct 30, 2018·Journal of Cellular and Molecular Medicine·Fang YeHu Zhou
Jul 7, 2020·Frontiers in Cell and Developmental Biology·Xinyue HuXing Yu
Dec 16, 2016·Journal of Cell Communication and Signaling·Evin İşcanNeşe Atabey
May 19, 2019·Nature Chemical Biology·Katsuya SakaiKunio Matsumoto
Jun 20, 2019·International Journal of Molecular Sciences·Nawaphat JangphattananontKunio Matsumoto
Mar 29, 2021·Current Opinion in Chemical Biology·Shota Taguchi, Hiroaki Suga
Dec 21, 2018·Journal of Medicinal Chemistry·Vishnu C DamalankaJames W Janetka
Sep 7, 2021·Cell Biology International·Zhan-Sheng ZhangDong Fang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.